VERTEX CONNECTS Trademark

Trademark Overview


On Tuesday, October 18, 2022, a trademark application was filed for VERTEX CONNECTS with the United States Patent and Trademark Office. The USPTO has given the VERTEX CONNECTS trademark a serial number of 97637068. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 12, 2024. This trademark is owned by Vertex Pharmaceuticals Incorporated. The VERTEX CONNECTS trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, providing classes, seminars, and workshops in the fields of medications, cell therapy and genetic therapy

Providing health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare

Providing medical and scientific research information in the field of cell therapy; providing pharmaceutical research and development in the field of cell therapy; Providing medical and scientific research information in the field of genetic therapy; providing pharmaceutical research and development in the field of genetic therapy
vertex connects

General Information


Serial Number97637068
Word MarkVERTEX CONNECTS
Filing DateTuesday, October 18, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements


Goods and ServicesEducational services, namely, providing classes, seminars, and workshops in the fields of medications, cell therapy and genetic therapy
Goods and ServicesProviding health information to patients, caregivers and health care professionals; providing health care information; providing patient education support services relating to medications, cell therapy and genetic therapy, in the nature of providing information about healthcare
Goods and ServicesProviding medical and scientific research information in the field of cell therapy; providing pharmaceutical research and development in the field of cell therapy; Providing medical and scientific research information in the field of genetic therapy; providing pharmaceutical research and development in the field of genetic therapy

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateSaturday, January 28, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 2, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 7, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events


Event DateEvent Description
Friday, December 23, 2022NON-FINAL ACTION E-MAILED
Friday, October 21, 2022NEW APPLICATION ENTERED
Wednesday, November 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 14, 2022ASSIGNED TO EXAMINER
Friday, December 23, 2022NON-FINAL ACTION WRITTEN
Friday, December 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, March 11, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, March 11, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, March 11, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, March 11, 2023EXAMINER'S AMENDMENT ENTERED
Saturday, March 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 1 FILED
Wednesday, December 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, June 12, 2024SOU EXTENSION 2 GRANTED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024SOU EXTENSION 2 FILED